EXACT Sciences

Exact Sciences’ next-gen colorectal cancer test hits primary goals in pivotal study
Exact Sciences’ next-gen colorectal cancer test hits primary goals in pivotal study
Medtech Dive
EXACT Sciences
Medtech
diagnostics
colorectal cancer
Cologuard
clinical trials
Flag link:
Diagnostics companies turn to restructuring in bid to preserve cash: Goldman
Diagnostics companies turn to restructuring in bid to preserve cash: Goldman
Medtech Dive
diagnostics
restructuring
Cue Health
GeneDx
Invitae
EXACT Sciences
Guardant Health
Flag link:
Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
Guardant DNA blood test finds 83% of colorectal cancers in trial, shares fall 35%
Reuters
Guardant Health
DNA
diagnostics
colorectal cancer
EXACT Sciences
Flag link:
Liquid biopsy developers take aim at colorectal cancer
Liquid biopsy developers take aim at colorectal cancer
EP Vantage
liquid biopsies
Medtech
diagnostics
colorectal cancer
EXACT Sciences
Guardant Health
Natera
Flag link:
Exact Sciences posts positive data on Cologuard 2.0 ahead of readouts on rival tests
Exact Sciences posts positive data on Cologuard 2.0 ahead of readouts on rival tests
Medtech Dive
diagnostics
Medtech
EXACT Sciences
Cologuard 2.0
clinical trials
colon cancer
Flag link:
A bad year to be an American medtech
A bad year to be an American medtech
EP Vantage
devices
Medtech
Europe
EXACT Sciences
Getinge
Guardant Health
Penumbra
Philips
Siemens Healthineers
Sonova
Straumann
Teladoc Health
Teleflex
Flag link:
Device deal making is back in a big way
Device deal making is back in a big way
EP Vantage
M&A
Medtech
devices
Siemens
Varian Medical Systems
Steris
Cantel Medical
Philips
BioTelemetry
EXACT Sciences
Thrive Earlier Detection
Hologic
Mobidiag
Flag link:
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
Exact Sciences Beat Expectations in Q1: Why Investors Didn't Jump for Joy
Motley Fool
EXACT Sciences
earnings
diagnostics
Flag link:
Medtech’s haves and have-nots
Medtech’s haves and have-nots
EP Vantage
earnings
devices
Medtech
Medtronic
EXACT Sciences
Thermo Fisher
Abbott Labs
Roche
Qiagen
JNJ
Zimmer Biomet
Smith & Nephew
Boston Scientific
Flag link:
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Medtech Dive
EXACT Sciences
Guardant Health
diagnostics
colorectal cancer
Ashion Analytics
M&A
Flag link:
Exact Sciences Falls in After-Hours Trading on Q4 Results
Exact Sciences Falls in After-Hours Trading on Q4 Results
Motley Fool
EXACT Sciences
earnings
Flag link:
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Yahoo/Benzinga
earnings
FDA
G1 Therapeutics
trilaciclib
Zoetis
EXACT Sciences
Blueprint Medicines
Ironwood Pharmaceuticals
Flag link:
The top medtech deals of 2020 (and one that got away)
The top medtech deals of 2020 (and one that got away)
Medtech Dive
devices
Medtech
M&A
Teladoc
Livongo Health
Stryker
Wright Medical
Medtronic
EXACT Sciences
Philips
BioTelemetry
Illumina
Grail
Siemens
Varian
Flag link:
A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain
A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain
Endpoints
EXACT Sciences
M&A
Thrive Earlier Detection
liquid biopsy
diagnostics
Flag link:
Exact gatecrashes the liquid biopsy party
Exact gatecrashes the liquid biopsy party
EP Vantage
EXACT Sciences
liquid biopsy
diagnostics
pan-cancer assay
Flag link:
Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
Exact Sciences Beats Q2 Estimates Despite a COVID-19 Drag
Motley Fool
EXACT Sciences
earnings
Flag link:
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Exact Sciences Acquires 2 Cancer Diagnostic Companies
Motley Fool
EXACT Sciences
M&A
diagnostics
cancer
Paradigm Diagnostics
Viomics
Flag link:
Exact Sciences Should Benefit from Pfizer’s News Today
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Pfizer
colorectal cancer
EXACT Sciences
FDA
Braftovi
Cologuard
Flag link:
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Flag link:
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Exact Sciences Gets FDA Nod for Label Expansion of Cologuard
Yahoo/Zacks.com
EXACT Sciences
Cologuard
diagnostics
colorectal cancer
Flag link:

Pages